JLK, Inc. (KOSDAQ:322510)

Market Cap	182.11B -17.1%
Revenue (ttm)	3.26B +99.4%
Net Income	-11.00B
EPS	-439.68
Shares Out	25.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	753,688
Average Volume	734,128
Open	7,410.00
Previous Close	7,480.00
Day's Range	7,140.00 - 7,900.00
52-Week Range	3,965.00 - 9,580.00
Beta	1.57
RSI	62.95
Earnings Date	Jan 23, 2026

About JLK, Inc.

JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, ...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 2014
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 322510

Financial Performance

In 2024, JLK, Inc.'s revenue was 1.43 billion, a decrease of -42.65% compared to the previous year's 2.49 billion. Losses were -13.45 billion, 83.7% more than in 2023.